Follicular atresia
(Redirected from Ovarian follicle atresia)
Follicular atresia is a biological process that occurs in the ovaries of female mammals. It involves the breakdown and subsequent absorption of ovarian follicles, which are the basic units of female reproductive biology. Each follicle contains an immature egg cell, or oocyte, and is capable of developing into a mature egg that can be fertilized by a sperm cell. However, the vast majority of follicles never reach this stage and instead undergo follicular atresia.
Process[edit | edit source]
Follicular atresia begins when a follicle ceases to mature. This can occur at any stage of development, from the primary follicle stage to the preovulatory stage. The process is regulated by a complex interplay of hormones, including estrogen, progesterone, and follicle-stimulating hormone (FSH). When a follicle is selected for atresia, its cells begin to die in a process known as apoptosis. The follicle then shrinks and is eventually absorbed by the ovary.
Role in Reproduction[edit | edit source]
The primary role of follicular atresia is to regulate the number of eggs that a female can produce during her reproductive lifetime. Only a small fraction of the follicles present at birth will ever mature into eggs; the rest will undergo atresia. This ensures that the female's reproductive resources are not depleted too quickly. In addition, follicular atresia plays a role in the selection of the most viable eggs for ovulation.
Clinical Significance[edit | edit source]
Abnormalities in the process of follicular atresia can lead to a variety of reproductive disorders. For example, premature ovarian failure, also known as premature ovarian insufficiency, can occur when too many follicles undergo atresia too quickly. This can lead to infertility and other health problems. On the other hand, a lack of follicular atresia can lead to polycystic ovary syndrome (PCOS), a condition characterized by the presence of many immature follicles in the ovaries.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD